News Headline Summary

FDA lift clinical hold on Pfizer arthritis drug Tanezumab

- Trial halted in 2010 over safety problems.

Reaction details (19:39)

- Shares showed no immediate reaction to the news, last trade at USD 23.32 (+0.66%).

09 Nov 2012 - 19:37 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: